SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 130 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $119,000 | – | 22,490 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Partners USVI, LLC | 152,500 | $697,000 | 2.61% |
| Trellus Management Company, LLC | 155,800 | $712,000 | 0.90% |
| WALL STREET ASSOCIATES | 942,200 | $4,306,000 | 0.40% |
| BAILARD, INC. | 340,500 | $1,556,000 | 0.30% |
| Baker Brothers Advisors | 2,608,271 | $11,920,000 | 0.17% |
| STONERIDGE INVESTMENT PARTNERS LLC | 104,158 | $476,000 | 0.10% |
| Cambridge Investment Research Advisors, Inc. | 449,080 | $2,052,000 | 0.09% |
| BTG Pactual Global Asset Management Ltd | 33,700 | $154,000 | 0.03% |
| HighTower Advisors, LLC | 242,001 | $1,106,000 | 0.03% |
| BHF Kleinwort Benson Group S.A. | 39,000 | $178,000 | 0.02% |